The Dermatology Digest
MARCH 7, 2025
Paradise Valley, AZ-based dermatologist Lindsay Ackerman, MD, identifies as a detective. “The skin, if read correctly, can tell an incredible story of what is going on inside the body,” she tells TDD at the launch of her new limited web series, Derm Detective: Demystifying Dermatology. “These clues allow us to play a leading role in the discovery of internal pathology.” Dr.
Beauty Launchpad
MARCH 7, 2025
Founder and CEO of Beyond the Ponytail, Angela Cattaneo dives into how she's creating a community for bridal stylists that allows them to grow and thrive, personally and professionally.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dermatology Times
MARCH 7, 2025
Published in JID, the paper analyzes the FDAs FAERS database and cases of neoplasms such as skin cancer, breast cancer, and other malignancies.
Kim Gallo Esthetics
MARCH 7, 2025
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission When it comes to skincare, few things cause more confusion than the difference between dry skin and dehydrated skin. They may share similar symptomstightness, dullness, and discomfortbut theyre not the same thing. Understanding which one youre dealing with is the crucial first step toward building a routine that helps your skin thrive.
Dermatology Times
MARCH 7, 2025
Ahead of the annual meeting, Dermatology Times spoke with Draelos about why she looks forward to the meeting each year.
The Dermatology Digest
MARCH 7, 2025
Tirbanibulin (Klisyri, Almirall) performs as well in real-world practice as it does in clinical trials for actinic keratosis (AK), according to new analyses of Phase III, phase IV, and real-world studies presented at the 2025 American Academy of Dermatology’s annual meeting in Orlando, FL. Tirbanibulin is U.S. Food and Drug Administration-approved for the treatment of AKs on the face or scalp up to 100 cm2.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
The Dermatology Digest
MARCH 7, 2025
Atopic dermatitis (AD) patients taking lebrikizumab (Ebglyss, Lilly) show a sustained depth of response for up to three years, according to new research presented at the2025American Academy of Dermatologys annual meeting in Orlando, FL.Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, discusses the topline results of the trial.
Dermatology Times
MARCH 7, 2025
Colleen Cotton, MD, shared clinical tips in treating HS in pediatric patients at the annual SPD Pre-AAD Meeting.
The Dermatology Digest
MARCH 7, 2025
Big things are happening at Tiger Aesthetics Medical, LLC. Industry vet Caroline (Caro) Van Hove is the new President and will oversee all U.S. Commercial Operations and Product Distribution. Van Hove previously held the position as CEO for Revelle Aesthetics, leading Revelle through the start-up phase to a successful acquisition by Tiger Aesthetics in 2024.
Dermatology Times
MARCH 7, 2025
The phase 2 trial of bimiralisib gel shows promising efficacy and safety for actinic keratosis, with up to 70% lesion clearance.
Dermatology Times
MARCH 7, 2025
Raj Chovatiya, MD, PhD, MSCI, discusses how early-career dermatologists can gain the most benefit from this years annual meeting.
Dermatology Times
MARCH 7, 2025
Jeanine Downie, MD, FAAD, discussed critical updates on tattoo ink safety, new dermatologic technologies, biostimulators, and more at AAD 2025.
Dermatology Times
MARCH 7, 2025
Alexandra P. Charrow, MD, FAAD, shares insights on the link between dermatology and irritable bowel disease at the AAD Annual Meeting.
Dermatology Times
MARCH 7, 2025
The company showcased advancements in tirbanibulin and its early-stage antibody LAD191.
Dermatology Times
MARCH 7, 2025
Adamson highlights key topics to expect at the AAD Annual Meeting, emphasizing the importance of tackling controversial issues and fostering collaboration.
Dermatology Times
MARCH 7, 2025
Along with his session insights on diet and chronic spontaneous urticaria, Friedman shares tips for navigating the largest dermatology conference in the US.
Dermatology Times
MARCH 7, 2025
Read more on how to navigate all the opportunities at this years AAD meeting, which starts today in Orlando, Florida.
Dermatology Times
MARCH 7, 2025
Linda Stein Gold, MD, FAAD, discusses the late-breaking tapinarof cream data presented at AAD 2025.
Dermatology Times
MARCH 7, 2025
Catch up on coverage from the first day of the 2025 American Academy of Dermatology Annual Meeting held in Orlando, Florida.
Dermatology Times
MARCH 7, 2025
Panelists discuss how clinicians can choose the most appropriate systemic treatment for moderate to severe atopic dermatitis by evaluating patient characteristics, comorbidities, and therapeutic goals while considering the latest clinical evidence.
Dermatology Times
MARCH 7, 2025
Panelists discuss how the JAK-STAT signaling pathway mediates inflammatory responses in atopic dermatitis, influencing disease progression and providing a key therapeutic target for treatment.
Expert insights. Personalized for you.
67 
Let's personalize your content